Haemonetics Corporation Share Price
NYSE: HAEHealthcare
Live Haemonetics Corporation Share Price Chart
O H L
Haemonetics Corporation Performance Overview
Days Range
▼
$108.18Low
$110.00High
Markets Today
| Previous Close | $107.60 |
|---|---|
| Open | $108.18 |
| Volume | 132,295 |
| Day's Range | $108.18 - $110.00 |
| 52W Range | $47.31 - $109.57 |
| Market Cap | $4.83 B |
Historical Performance
| 1M Returns | +2.82 |
|---|---|
| 3M Returns | +45.07 |
| 6M Returns | +80.78 |
| 1Y Returns | +110.36 |
| 5Y Returns | +53.23 |
| 10Y Returns | +189.01 |
Haemonetics Corporation Fundamentals
| Market Cap | $4.83 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 51.24 |
| PEG Ratio | N/A |
| Revenue | $1.33 B |
| ROE TTM | 0.12 |
| EPS TTM | $2.07 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 5.77 |
| EBITDA | $355.00 M |
| Profit Margin | 7.29 |
| Market Cap | $4.83 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 51.24 |
| PEG Ratio | N/A |
| Revenue | $1.33 B |
| ROE TTM | 0.12 |
| EPS TTM | $2.07 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 5.77 |
| EBITDA | $355.00 M |
| Profit Margin | 7.29 |
Haemonetics Corporation Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $330.60 M | $321.39 M | $327.31 M | $338.97 M | $346.35 M | $339.38 M |
| Gross Profit + | $193.05 M | $192.24 M | $194.74 M | $202.39 M | $198.21 M | $202.80 M |
| Operating Income | $71.33 M | $53.87 M | $58.49 M | $67.40 M | -$23.02 M | $57.46 M |
| EBITDA | $87.22 M | $82.63 M | $97.39 M | $96.82 M | $75.73 M | $84.57 M |
| Interest Expense | $0 | -$8.70 M | $0 | $0 | $0 | -$9.88 M |
| Depreciation | $15.89 M | $28.76 M | $38.89 M | $29.42 M | $98.75 M | $27.11 M |
| Income Before Tax | $70.74 M | $45.17 M | $51.28 M | $59.98 M | -$28.40 M | $47.57 M |
| Income Tax Expense | $12.76 M | $11.14 M | $12.60 M | $15.23 M | -$8.25 M | $14.56 M |
| Net Income + | $57.98 M | $34.03 M | $38.68 M | $44.74 M | -$20.15 M | $33.01 M |
| Net Profit Margin | 17.54% | 10.59% | 11.82% | 13.2% | -5.82% | 9.73% |
Haemonetics Corporation Financials Balance Sheet In USD
Quarterly
| Dec 2025 | Dec 2025 | Mar 2026 | Mar 2026 | Jun 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $468.00 K | $468.00 K | $453.00 K | $453.00 K | $455.00 K | $455.00 K |
| Reserve & Surplus | $346.48 M | $346.48 M | $241.73 M | $241.73 M | $269.89 M | $269.89 M |
| Non-Current Liabilities | $1.04 B | $1.04 B | $1.32 B | $1.32 B | $1.27 B | $1.27 B |
| Current Liabilities | $539.87 M | $539.87 M | $282.60 M | $282.60 M | $263.24 M | $263.24 M |
| Total Liabilities | $1.58 B | $1.58 B | $1.60 B | $1.60 B | $1.53 B | $1.53 B |
| Fixed Assets | $716.97 M | $716.97 M | $753.42 M | $753.42 M | $738.29 M | $738.29 M |
| Current Assets | $943.67 M | $943.67 M | $834.88 M | $834.88 M | $810.83 M | $810.83 M |
| Total Assets | $2.49 B | $2.49 B | $2.40 B | $2.40 B | $2.37 B | $2.37 B |
Haemonetics Corporation Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | $57.98 M | $34.03 M | $38.68 M | $44.74 M | -$20.15 M | $33.01 M |
| Operating Cash Flow | $116.56 M | $17.39 M | $111.32 M | $93.56 M | $70.94 M | $52.32 M |
| Investing Cash Flow | $18.04 M | -$33.00 M | -$30.47 M | -$29.47 M | -$86.61 M | -$22.23 M |
| Financing Cash Flow | -$151.45 M | -$2.44 M | -$76.55 M | $2.03 M | -$101.50 M | -$51.53 M |
| Change in Cash | -$14.08 M | -$13.87 M | $3.53 M | $66.94 M | -$117.93 M | -$22.06 M |
Haemonetics Corporation Peer Comparison
| Company | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|
 | $9.75B | -51.60% | 26.30 | 9.12% | 0.00% |
 | $32.96B | -37.54% | 34.65 | 17.94% | 0.00% |
 | $137.62M | -93.79% | 0.00 | -77.14% | 0.00% |
 | $830.94M | -24.39% | 0.00 | -9.41% | 0.00% |
 | $12.54B | 11.99% | 78.20 | 12.66% | 0.00% |
 | $18.46B | -35.76% | 23.56 | 8.57% | 0.99% |
 | $6.57B | 293.75% | 24.32 | 15.15% | 0.00% |
 | $7.94B | 47.53% | 34.69 | 16.38% | 0.00% |
Haemonetics Corporation Return Calculator
The Haemonetics Corporation stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$15,612
Invested Amount$10,000
Est. Returns$5,612
About Haemonetics Corporation
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.
Popular Stocks
FAQs
What is the share price of Haemonetics Corporation today?
Haemonetics Corporation (HAE) share price as of September 18, 2026 is $109.63. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Haemonetics Corporation?
Yes, Indian Investors can invest in the Haemonetics Corporation (HAE) Share by opening an international trading account with Angel One.
How can I purchase Haemonetics Corporation shares in India?
Purchasing Haemonetics Corporation (HAE) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Haemonetics Corporation (HAE) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Haemonetics Corporation?
Yes, you can purchase fractional shares of Haemonetics Corporation (HAE) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Haemonetics Corporation?
The market capitalization of Haemonetics Corporation on September 18, 2026, is $4.83 B.
In which sector Haemonetics Corporation belongs?
Haemonetics Corporation operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Haemonetics Corporation stocks?
In order to invest in Haemonetics Corporation (HAE) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
